Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Telemetric intracranial pressure monitoring in children

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prognostic factors for relapse in patients with clinical stage I testicular cancer: Protocol for a Danish nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Cochlear MRI Signal Change Following Vestibular Schwannoma Resection Depends on Surgical Approach

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Gemcitabine for recurrent ovarian cancer - a systematic review and meta-analysis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer
To evaluate long-term tumor control and hearing preservation rates in patients with vestibular schwannoma treated with fractionated stereotactic radiotherapy (FSRT), comparing hearing preservation rates to an untreated control group. The relationship between radiation dose to the cochlea and hearing preservation was also investigated.
OriginalsprogEngelsk
TidsskriftInternational Journal of Radiation: Oncology - Biology - Physics
Vol/bind83
Udgave nummer5
Sider (fra-til)e607-11
ISSN0360-3016
DOI
StatusUdgivet - 2012

ID: 36486708